Table 2 Dosimetric parameters for the target and organs at risk over 95 investigated fractions from \(\:{\text{T}\text{P}}_{\text{a}\text{d}\text{a}\text{p}}\) and \(\:{\text{T}\text{P}}_{\text{I}\text{G}\text{R}\text{T}}\) plans. Median values are shown, with the range in parenthesis. Significant differences ( p < 0.05) are indicated in bold
From: Dose tracking assessment for magnetic resonance guided adaptive radiotherapy of rectal cancers
| Â | \(\:{\mathbf{T}\mathbf{P}}_{\mathbf{A}\mathbf{D}\mathbf{A}\mathbf{P}}\) | \(\:{\mathbf{T}\mathbf{P}}_{\mathbf{I}\mathbf{G}\mathbf{R}\mathbf{T}}\) | p |
|---|---|---|---|
PTV \(\:{\text{V}}_{23.75}\) (%) | 99.59 (98.88–99.85) | 99.23 (95.28–100.00) | < 0.001 |
PTV \(\:{\text{V}}_{26.75}\) (cc) | 1.71 (0.00-5.95) | 7.9 (0.04–43.80) | < 0.001 |
Bladder \(\:{\text{D}}_{15\text{c}\text{c}}\) (Gy) | 18.18 (13.07–23.32) | 19.60 (15.07–24.37) | < 0.001 |
Small Bowel \(\:{\text{D}}_{5\text{c}\text{c}}\) (Gy) | 23.40 (13.88–24.80) | 25.69 (14.05–26.43) | < 0.001 |